Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Lymphoma

  Free Subscription

Articles published in Lab Invest

Retrieve available abstracts of 5 articles:
HTML format
Text format

Single Articles

    August 2017
  1. JIANG N, Chen C, Gong Q, Shields K, et al
    Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.
    Lab Invest. 2017 Aug 7. doi: 10.1038/labinvest.2017.
    PubMed     Text format     Abstract available

    July 2017
  2. KNECHT H, Johnson NA, Haliotis T, Lichtensztejn D, et al
    Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.
    Lab Invest. 2017;97:772-781.
    PubMed     Text format     Abstract available

    June 2017
  3. SCHMIDT J, Bonzheim I, Steinhilber J, Montes-Mojarro IA, et al
    EMMPRIN (CD147) is induced by C/EBPbeta and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma.
    Lab Invest. 2017 Jun 5. doi: 10.1038/labinvest.2017.
    PubMed     Text format     Abstract available

    April 2017
  4. HWANG SR, Murga-Zamalloa C, Brown N, Basappa J, et al
    Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.
    Lab Invest. 2017 Apr 17. doi: 10.1038/labinvest.2017.
    PubMed     Text format     Abstract available

    February 2016
  5. WADA N, Ikeda JI, Nojima S, Tahara SI, et al
    Requirement of CXCL12-CXCR7 signaling for CD20 CD138 double-negative population in lymphoplasmacytic lymphoma.
    Lab Invest. 2016 Feb 15. doi: 10.1038/labinvest.2016.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.